332 related articles for article (PubMed ID: 7583549)
1. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Miserez AR; Keller U
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
[TBL] [Abstract][Full Text] [Related]
2. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
[TBL] [Abstract][Full Text] [Related]
3. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
[TBL] [Abstract][Full Text] [Related]
4. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
5. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
Miserez AR; Martin FJ; Spirk D
Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
[TBL] [Abstract][Full Text] [Related]
6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
7. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
Gaffney D; Forster L; Caslake MJ; Bedford D; Stewart JP; Stewart G; Wieringa G; Dominiczak M; Miller JP; Packard CJ
Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
[TBL] [Abstract][Full Text] [Related]
8. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
[TBL] [Abstract][Full Text] [Related]
9. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
Morash B; Guernsey DL; Tan MH; Dempsey G; Nassar BA
Clin Biochem; 1994 Aug; 27(4):265-72. PubMed ID: 8001287
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
Ejarque I; Real JT; Martinez-Hervas S; Chaves FJ; Blesa S; Garcia-Garcia AB; Millan E; Ascaso JF; Carmena R
Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815
[TBL] [Abstract][Full Text] [Related]
11. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
[TBL] [Abstract][Full Text] [Related]
12. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
Ceska R; Vrablík M; Horínek A
Physiol Res; 2000; 49 Suppl 1():S125-30. PubMed ID: 10984082
[TBL] [Abstract][Full Text] [Related]
13. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
[TBL] [Abstract][Full Text] [Related]
15. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
Tai ES; Koay ES; Chan E; Seng TJ; Loh LM; Sethi SK; Tan CE
Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries.
Hansen PS; Defesche JC; Kastelein JJ; Gerdes LU; Fraza L; Gerdes C; Tato F; Jensen HK; Jensen LG; Klausen IC; Faergeman O; Schuster H
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):741-7. PubMed ID: 9108789
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
Brugger D; Schuster H; Zöllner N
Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
[TBL] [Abstract][Full Text] [Related]
18. [DNA analysis in heterozygotes in familial hypercholesterolemia].
Horínek A; Slézka V; Sobra J; Ceska R
Cas Lek Cesk; 1995 Apr; 134(8):234-9. PubMed ID: 7758080
[TBL] [Abstract][Full Text] [Related]
19. Familial hypercholesterolemia due to ligand-defective apolipoprotein B100: first case report in a Mexican family.
Robles-Osorio L; Ordoñez ML; Aguilar-Salinas CA; Aurón-Gómez M; Tusié-Luna MT; Gómez-Pérez FJ; Rull-Rodrigo JA
Arch Med Res; 2003; 34(1):70-5. PubMed ID: 12604379
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and biochemical characteristics of familial ligand-defective apo B-100 in a South European population].
Ejarque I; Real JT; Chaves FJ; Blesa S; González V; Milian E; Ascaso JF; Priego MA; Carmena R
Med Clin (Barc); 2004 Oct; 123(12):456-9. PubMed ID: 15498441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
